Patient-centric Dose Design
Summary: Orally disintegrating tablets (ODT) offer many benefits to developers looking to avoid some of the limitations of conventional tablet dose forms, and in better addressing the needs of certain patient groups such as the young and elderly. If the convenience of a dose form that can be taken on-the-go, or patient-centric characteristics such as fast onset or easy administration are desired, then an ODT may prove to be the best choice
Read the article published in the Manufacturing Chemist summarizing the latest developments in orally disintegrating tablets. It highlights Catalent’s Zydis ODT, which powers ~35 products formulations on the market in more than 60 countries.